Bio Rad Laboratories Inc (NYSE:BIO)

288.64
BATS BZX Real-Time Price
As of 2:51pm ET
 -0.27 / -0.09%
Today’s Change
208.95
Today|||52-Week Range
297.59
+20.94%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$7.1B

Company Description

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Contact Information

Bio-Rad Laboratories, Inc.
1000 Alfred Nobel Drive
Hercules California 94547
P:(510) 724-7000
Investor Relations:

Employees

Shareholders

Other institutional41.20%
Mutual fund holders37.04%
Individual stakeholders26.26%

Top Executives

Norman D. SchwartzChairman, President & Chief Executive Officer
Christine A. TsingosChief Financial Officer & Executive Vice President
Giovanni MagniChief Strategy Officer & Executive Vice President
John HertiaEVP & President-Clinical Diagnostics Group
Shannon HallExecutive VP & President-Life Science Group